Iris Löw-Friedrich (UCB Pharma S.A.)

Löw-Friedrich, Iris (UCB 201403 CMO before Schwarz Pharma)

	Organisation	UCB Pharma S.A.
	Group	UCB (Group)
	Former/major organisation	Schwarz Pharma AG
	Today	UCB Pharma GmbH
	Group	UCB (Group)
	Product	pharmaceutical
	Product 2	CNS drug (neurological drug)

Record changed: 2024-11-29

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Iris Löw-Friedrich

[1] Evotec SE. (11/29/24). "Press Release: Evotec Announces Change in Management Board. Dr Craig Johnstone Steps Down as Chief Operating Officer Effective 31 December 2024". Hamburg....
[2] Halozyme Therapeutics, Inc.. (11/22/24). "Press Release: Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions". San Diego, CA....
[3] Evotec SE. (9/3/24). "Press Release: Evotec Announces Change in Management Board. Dr Matthias Evers Steps Down as Chief Business Officer Effective 01 October 2024". Hamburg....
[4] Evotec SE. (6/10/24). "Press Release: Results of the Annual General Meeting 2024". Hamburg....
[5] Evotec SE. (4/23/24). "Press Release: Evotec SE Appoints Dr Christian Wojczewski as Chief Executive Officer". Hamburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]